全身PET/MRI在儿童肿瘤学中的应用
本文聚焦全身PET/MRI在儿童肿瘤影像中的实践与效用。儿童肿瘤方案主要为全身方案;PET/MRI相较PET/CT的优势包括降低辐射暴露、减少镇静与全身麻醉事件、单日一站式就诊,以及同时使用两种独立先进影像技术进行分期和疗效评估。
要点
- 儿童外颅实体瘤的分期和疗效评估当前影像标准为氟-18标记FDG PET/CT与MRI。
- PET/MRI在一次检查中结合解剖与生理成像,相较CT降低辐射。
- PET/MRI相较PET/CT的优势包括降低辐射暴露、减少镇静和全身麻醉事件、单日一站式就诊及同时成像。
核心结论
- PET/MRI相较PET/CT的优势令人信服,包括降低辐射暴露、减少镇静和全身麻醉事件、单日一站式就诊,以及同时使用两种独立先进影像技术进行分期和疗效评估。
研究设计与样本
- 本文为论述全身PET/MRI在儿童肿瘤影像中实践与效用的文章,未报告系统检索范围与纳入文献。
临床应用与阅片要点
- 儿童肿瘤方案主要采用全身方案,源于儿童特有癌症的行为和类型。
- 氟-18标记FDG PET/CT与MRI是儿童外颅实体瘤分期、疗效评估和复发评估的当前影像标准。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE. Fluorine-18-labeled FDG PET/CT and MRI are current imaging standards for staging and assessing tumor response and recurrence of pediatric extracranial solid tumors. PET/MRI combines anatomic and physiologic imaging in a single session with reduced radiation compared with CT. Pediatric protocols are primarily whole-body protocols because of the behavior and type of cancers unique to children. This article will focus on the practice and utility of whole-body PET/MRI for pediatric oncologic imaging. CONCLUSION. The strengths of PET/MRI over PET/CT are compelling and include decreased radiation exposure, decreased number of sedation and general anesthesia events, single-day one-stop visits, and simultaneous imaging with two stand-alone advanced imaging techniques essential to staging and assessing treatment response in pediatric oncology.
引用
- States LJ, Reid JR. Whole-Body PET/MRI Applications in Pediatric Oncology. AJR Am J Roentgenol. 2020. PMID: 32755171. doi:10.2214/AJR.19.22677
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。